Study of LYC-55716 in Adult Subjects With Locally Advanced or Metastatic Cancer
Lay Description
This is a Phase 1/2A study designed to evaluate the safety and tolerability of increased repeated doses of LYC-55716 in subjects with locally advanced or metastatic solid tumors.
Category
- Diabetes
- Minority Studies
- IRB Number
- 20170647HU
- NCT Number
- ct.gov registration not required
- Open to Enrollment
- Yes
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Genders
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
Exclusion Criteria
Study Design
Arm Groups
Study Contact
Juliana Lopez
9565886655
lopezj21@uthscsa.edu
Principal Investigator
Joseph Mccormick